UY27971A1 - Derivados de piperidina - Google Patents

Derivados de piperidina

Info

Publication number
UY27971A1
UY27971A1 UY27971A UY27971A UY27971A1 UY 27971 A1 UY27971 A1 UY 27971A1 UY 27971 A UY27971 A UY 27971A UY 27971 A UY27971 A UY 27971A UY 27971 A1 UY27971 A1 UY 27971A1
Authority
UY
Uruguay
Prior art keywords
piperidine derivatives
inhibition
tace
metalloproteinases
malignancies
Prior art date
Application number
UY27971A
Other languages
English (en)
Inventor
Howard Tudker
Jeremy Nicholas Burrows
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY27971A1 publication Critical patent/UY27971A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Derivados de piperidina útiles en la inhibición de metaloproteínasas y en particular en la inhibición de la Enzima Convertidora de TNF-a (TACE) y por lo tanto en el tratamiento de enfermedades inflamatorias, autoinmunes, alérgicas / atópicas, rechazo de transplantes, enfermedad del injerto contra el huésped, enfermedades cardiovasculares, lesiones por reperfusión y malignidades.
UY27971A 2002-09-13 2003-09-11 Derivados de piperidina UY27971A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0221250.4A GB0221250D0 (en) 2002-09-13 2002-09-13 Compounds

Publications (1)

Publication Number Publication Date
UY27971A1 true UY27971A1 (es) 2004-04-30

Family

ID=9944003

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27971A UY27971A1 (es) 2002-09-13 2003-09-11 Derivados de piperidina

Country Status (9)

Country Link
US (1) US20060019994A1 (es)
EP (1) EP1539706A1 (es)
JP (1) JP2006500404A (es)
AR (1) AR041196A1 (es)
AU (1) AU2003264753A1 (es)
GB (1) GB0221250D0 (es)
TW (1) TW200405894A (es)
UY (1) UY27971A1 (es)
WO (1) WO2004024698A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100902D0 (sv) 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0103710D0 (sv) 2001-11-07 2001-11-07 Astrazeneca Ab Compounds
SE0202539D0 (sv) 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
SE0401762D0 (sv) 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
SE0401763D0 (sv) * 2004-07-05 2004-07-05 Astrazeneca Ab Compounds
US7504424B2 (en) 2004-07-16 2009-03-17 Schering Corporation Compounds for the treatment of inflammatory disorders
AU2005275213A1 (en) 2004-07-16 2006-02-23 Schering Corporation Hydantoin derivatives for the treatment of inflammatory disorders
US7488745B2 (en) 2004-07-16 2009-02-10 Schering Corporation Compounds for the treatment of inflammatory disorders
PE20071240A1 (es) 2006-01-17 2008-01-14 Schering Corp Compuestos derivados de hidantoina para el tratamiento de trastornos inflamatorios
TW200740769A (en) * 2006-03-16 2007-11-01 Astrazeneca Ab Novel process
TW200831488A (en) * 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds
TW201024304A (en) 2008-09-24 2010-07-01 Schering Corp Compounds for the treatment of inflammatory disorders
WO2010036640A2 (en) 2008-09-24 2010-04-01 Schering Corporation Compounds for the treatment of inflammatory disorders
US8541572B2 (en) 2008-11-10 2013-09-24 Merck Sharp & Dohme Corp. Compounds for the treatment of inflammatory disorders
EP2355825A2 (en) 2008-11-10 2011-08-17 Schering Corporation Compounds for the treatment of inflammatory disorders
GB201610056D0 (en) * 2016-06-09 2016-07-27 Galapagos Nv And Laboratoires Servier Les Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis
CN115052596B (zh) * 2020-02-04 2024-06-14 江苏恒瑞医药股份有限公司 Adamts抑制剂、其制备方法和医药用途
CN117136051A (zh) * 2021-04-02 2023-11-28 江苏恒瑞医药股份有限公司 Adamts抑制剂的前药、其制备方法和医药用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012477A1 (en) * 1998-08-29 2000-03-09 British Biotech Pharmaceuticals Limited Hydroxamic acid derivatives as proteinase inhibitors
GB9919776D0 (en) * 1998-08-31 1999-10-27 Zeneca Ltd Compoujnds
SK10932003A3 (sk) * 2001-03-15 2004-04-06 Astrazeneca Ab Metaloproteinázové inhibítory

Also Published As

Publication number Publication date
GB0221250D0 (en) 2002-10-23
AR041196A1 (es) 2005-05-04
US20060019994A1 (en) 2006-01-26
EP1539706A1 (en) 2005-06-15
TW200405894A (en) 2004-04-16
AU2003264753A1 (en) 2004-04-30
WO2004024698A1 (en) 2004-03-25
JP2006500404A (ja) 2006-01-05

Similar Documents

Publication Publication Date Title
UY27971A1 (es) Derivados de piperidina
MXPA06011046A (es) Ciertos compuestos basados en triazol, composiciones, y usos de los mismos.
BRPI0409367A (pt) derivados de piperidina inibidores de renina
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
SE0201980D0 (sv) Novel compounds
IL172506A0 (en) New biological entities and the use thereof
CY1107342T1 (el) Χρηση παραγωγων νιτριλιου ως φαρμακο
WO2006020767A3 (en) Thiazole based inhibitors of atp-utilizing enzymes
DK1776349T3 (da) 2-amino-puinazolin derivater anvendelige som inhibitorer af beta-sekretase (BACE)
NO20061291L (no) Ny formulering
UY27362A1 (es) Métodos de usar inhibidores de epóxido hidrolasa soluble
NO20055741D0 (no) Nye kjemiske forbindelser
NO20044658L (no) Anvendelse av osteoprotegerin til behandling og/eller forhindring av fibrotiske sykdommer
DE60310767D1 (de) PYRAZOL-3,4-d-PYRIMIDINDERIVATE UND IHRE VERWENDUNG BEI DER BEHANDLUNG VON H.PYLORI-INFEKTIONEN
MA30485B1 (fr) Aminothiazoles et leurs utilisations
WO2007011757A8 (en) Use of inhibitors of the ubiquitin proteasome pathway for increasing contractility of the heart
SE0302304D0 (sv) Novel compounds
NO20054670D0 (no) Behandling av intestinale tilstander med N-2,3,3-tetrametylbisyklo[2.2.1]-heptan-2-amid
ATE497506T1 (de) Sars-verwandte proteine
NO20060781L (no) Anvendelse av loselig CD164 ved inflammatoriske og/eller autoimmune lidelser
ATE399532T1 (de) Medizinische seife
WO2003070229A3 (de) Verwendung von proteinaseinhibitoren zur behandlung von autoimmunerkrankungen
NO20060420L (no) 2-aminobenzoylderivater
SE0203712D0 (sv) Novel compounds
DK1926472T3 (da) Stabiliserede og konserverede ketotifenholdige oftalmiske sammensætninger

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150417